In this study, we evaluated the effect of WS-5 on in vitro amyloidogenic activity, which was assessed as activity against Aβ aggregation, acetylcholinesterase, and oxidative stress, and on an in vivo Alzheimer's disease induced in mice by Aβ infarction. This evidence concerns the gene ACHE and Alzheimer disease.